CRON.TO
Cronos Group Inc
Price:  
3.31 
CAD
Volume:  
81,340.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRON.TO EV/EBITDA

-21.4%
Upside

As of 2026-03-23, the EV/EBITDA ratio of Cronos Group Inc (CRON.TO) is -15.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CRON.TO's latest enterprise value is 168.00 mil CAD. CRON.TO's TTM EBITDA according to its financial statements is -11.04 mil CAD. Dividing these 2 quantities gives us the above CRON.TO EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 4.6x - 8.5x 6.5x
Forward P/E multiples 4.8x - 10.3x 6.8x
Fair Price 2.68 - 2.53 2.60
Upside -19.1% - -23.7% -21.4%
3.31 CAD
Stock Price
2.60 CAD
Fair Price

CRON.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-03-20 -41.93
2026-03-19 -43.99
2026-03-18 -48.45
2026-03-17 -50.17
2026-03-16 -48.45
2026-03-13 -46.39
2026-03-12 -44.68
2026-03-11 -47.77
2026-03-10 -46.39
2026-03-09 -46.05
2026-03-06 -48.80
2026-03-05 -49.14
2026-03-04 -51.89
2026-03-03 -50.51
2026-03-02 -52.23
2026-02-27 -53.95
2026-02-26 -54.29
2026-02-25 -58.75
2026-02-24 -56.69
2026-02-23 -52.57
2026-02-20 -54.29
2026-02-19 -56.01
2026-02-18 -53.60
2026-02-17 -53.26
2026-02-13 -50.17
2026-02-12 -49.14
2026-02-11 -50.51
2026-02-10 -52.92
2026-02-09 -50.86
2026-02-06 -51.89
2026-02-05 -48.80
2026-02-04 -49.48
2026-02-03 -49.48
2026-02-02 -46.05
2026-01-30 -45.02
2026-01-29 -48.45
2026-01-28 -52.57
2026-01-27 -55.66
2026-01-26 -54.98
2026-01-23 -59.44
2026-01-22 -56.35
2026-01-21 -51.89
2026-01-20 -49.14
2026-01-19 -49.48
2026-01-16 -49.48
2026-01-15 -51.54
2026-01-14 -53.95
2026-01-13 -57.04
2026-01-12 -55.66
2026-01-09 -56.35